|
|
|
Á¤°æÈñ ( Chung Kyung-Hee ) - ³²ºÎ´ëÇб³ °£È£Çаú
°í¿µ¼÷ ( Ko Young-Sook ) - Æò¾çº¸°Ç´ëÇÐ °£È£°ú ÀÓÁ¤¾Æ ( Lim Jeong-Ah ) - ¹«¾È³ëÀοä¾çº´¿ø
|
|
Abstract
|
|
|
|
Purpose: The purpose of this study was to develop a Critical Pathway for Uterine Artery Embolization patients.
Method: There were 6 steps that were taken. Step 1 was selecting a diagnosis, and Step 2 was organizing a development team consisting of 7 experts. Step 3 analyzed the medical records, and Step 4 drew up a preliminary Critical Pathway. Step 5 tested the clinical validity of the preliminary Critical Pathway, and Step 6 developed the final Critical Pathway.
Result: The contents of the medical practices observed in the medical records were investigated in seven areas: monitoring/assessment, treatment, medication, diet, activity, consults, and education/discharge plan; and a total of 73 items was identified. The validity of the 73 items was examined by a group of specialists. 68 items were adopted, 4 items revised, 1 item removed, and 1 item was added. Using the results, a preliminary Critical Pathway was drawn up. According to the results from examining the clinical validity of the preliminary Critical Pathway with five patients for five weeks, 3 items which showed discrepancy were revised and another 3 items were added. Then, the final Critical Pathway was completed.
Conclusion: This Critical Pathway needs to be clinically applied and continuously to measure its effects in terms of the length of stay, cost?effectiveness, and the patients¡¯ and staffs¡¯ satisfaction.
|
|
KeyWords
|
|
Critical pathway, Uterine artery embolization
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|